Valerie Jolivel
Gutenberg, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis.
Journal: Neurology and therapy
Published: March 07, 2022
Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection.
Journal: Cells
Published: January 19, 2021
Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 11, 2020
Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelination.
Journal: EMBO molecular medicine
Published: January 26, 2019
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 16, 2014
Perivascular microglia promote blood vessel disintegration in the ischemic penumbra.
Journal: Acta neuropathologica
Published: June 02, 2014
NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: June 28, 2013
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Journal: International immunopharmacology
Published: June 25, 2013
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Journal: Brain : a journal of neurology
Published: March 23, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026